Quantbot Technologies LP Cuts Stock Holdings in U.S. Physical Therapy, Inc. (NYSE:USPH)

Quantbot Technologies LP trimmed its stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 32.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,357 shares of the company's stock after selling 3,519 shares during the quarter. Quantbot Technologies LP's holdings in U.S. Physical Therapy were worth $653,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also bought and sold shares of the stock. CBIZ Investment Advisory Services LLC grew its holdings in shares of U.S. Physical Therapy by 59.8% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company's stock worth $29,000 after purchasing an additional 122 shares during the last quarter. Venturi Wealth Management LLC boosted its holdings in shares of U.S. Physical Therapy by 3,200.0% during the fourth quarter. Venturi Wealth Management LLC now owns 726 shares of the company's stock worth $64,000 after purchasing an additional 704 shares during the period. Pacer Advisors Inc. bought a new stake in shares of U.S. Physical Therapy in the fourth quarter worth about $113,000. Mutual of America Capital Management LLC purchased a new position in U.S. Physical Therapy during the 4th quarter valued at about $203,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank raised its position in U.S. Physical Therapy by 57.1% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,631 shares of the company's stock valued at $223,000 after purchasing an additional 956 shares during the last quarter.

U.S. Physical Therapy Stock Up 0.7 %

Shares of NYSE:USPH traded up $0.50 on Monday, hitting $72.43. 137,036 shares of the company traded hands, compared to its average volume of 103,445. The stock has a 50 day simple moving average of $82.93 and a 200-day simple moving average of $86.52. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27. The company has a market cap of $1.10 billion, a PE ratio of 77.05, a PEG ratio of 3.54 and a beta of 1.51. U.S. Physical Therapy, Inc. has a 52 week low of $69.99 and a 52 week high of $113.63.

Remove Ads

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its earnings results on Wednesday, February 26th. The company reported $0.65 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.69 by ($0.04). The firm had revenue of $180.45 million during the quarter, compared to analysts' expectations of $173.10 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. As a group, research analysts expect that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 14th will be paid a $0.45 dividend. The ex-dividend date is Friday, March 14th. This is a boost from U.S. Physical Therapy's previous quarterly dividend of $0.44. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.49%. U.S. Physical Therapy's dividend payout ratio is 97.83%.

Insider Activity at U.S. Physical Therapy

In related news, COO Graham D. Reeve sold 1,730 shares of the stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $82.11, for a total transaction of $142,050.30. Following the completion of the sale, the chief operating officer now owns 7,168 shares in the company, valued at approximately $588,564.48. This trade represents a 19.44 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.70% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on USPH shares. StockNews.com lowered U.S. Physical Therapy from a "hold" rating to a "sell" rating in a research report on Friday, February 28th. JMP Securities initiated coverage on shares of U.S. Physical Therapy in a research report on Monday, December 16th. They set an "outperform" rating and a $113.00 price objective on the stock. Bank of America raised shares of U.S. Physical Therapy from a "neutral" rating to a "buy" rating and raised their target price for the stock from $100.00 to $115.00 in a research report on Monday, December 16th. Barrington Research reduced their price target on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating on the stock in a research report on Friday, February 28th. Finally, William Blair restated a "market perform" rating on shares of U.S. Physical Therapy in a report on Thursday, February 27th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, four have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $109.00.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.